CIK: 1277422 - Address: C/o Scolr Pharma, Inc., 3625 - 132Nd Avenue S.E. Suite 300, Bellevue, WA 98006
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/8/05 19:46
6/7/05
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticVitulli GailWAODir FinaM.d10.660052627D2598827172012151063-18-14
12/21/04 18:04
12/17/04
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticVitulli GailWAODir of FM.d70.66002106725D1246654491051826309416
5/27/04 14:40
5/25/04
DDDScolr IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVitulli GailWAODIR OF FM.d30.6600055015D-71422911-50370-6-514883

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact